Comparing Aerobic to Resistance Training in Recovery From Cancer

Neoplasms Clinical Trial

Official title:

Comparing Aerobic to Resistance Training in Recovery From Cancer

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00237926
• Other study ID #: N05-006
• Status: Completed
• Phase: N/A
• First received: October 11, 2005
• Last updated: July 29, 2008
• Start date: November 2005

Study information

• Verified date: July 2008
• Source: Brooke Army Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to compare the health outcomes of a 12-week exercise program focused on aerobic training (using a treadmill) to a 12-week exercise program focused on resistance training (using Thera-Bands) in sedentary patients within 6 months of completing treatment for cancer.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 58
• Est. primary completion date: March 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• have a biopsy-proven cancer diagnosis

• be within six months of having completed chemotherapy or radiation therapy for treatment for cancer as determined by the primary physician

• be ambulatory but sedentary (i. e., has not followed an exercise regimen of a minimum of 3 times per week for at least 20 minutes each session over the previous six weeks)

• have an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 asymptomatic) or 1 (symptomatic, fully ambulatory)

• be at least 18 years old

• be able to read and speak English

• have a medical statement from either the patient's primary care provider or the primary oncologist indicating that participation in the program is not medically contraindicated

Exclusion Criteria:

• following an exercise regimen a minimum of 3 times per week for at least 20 minutes each session within the previous 6 weeks

• bone or joint destruction that could be aggravated with exercise

• severe cognitive impairment identified by either the patient's medical care provider or by the study team

• neuropathy-sensory common toxicity criteria (CTC) grade 3 (sensory loss or paresthesia interfering with activities of daily living) or grade 4 (permanent sensory loss that interferes with function) peripheral neuropathy

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Neoplasms

Intervention

Behavioral:
• Exercise
aerobic or resistance training

Locations

Country	Name	City	State
United States	Brooke Army Medical Center	Fort Sam Houston	Texas

Sponsors (1)

Lead Sponsor	Collaborator
TriService Nursing Research Program

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	quality of life		12-weeks	No
Secondary	exercise tolerance		12-weeks	No